|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.8 USD | 0.00% |
|
0.00% | -5.26% |
| Apr. 18 | Verastem Names John Hayslip as Chief Medical Officer | MT |
| Apr. 15 | I-Mab Announces Chief Medical Officer Changes | CI |
Feb 7 (Reuters) - I-Mab said on Wednesday that it has agreed to divest its operations and assets in China, as part of its strategy to become a U.S.-focused biotech firm.
The company said it will transfer the ownership of its China unit, I-Mab Shanghai, to its affiliate Hangzhou Company for a total consideration of upto $80 million. (Reporting by Bhanvi Satija in Bengaluru; Editing by Varun H K)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 2,686 PTS | +0.86% | +2.29% | - | ||
| 1.8 USD | 0.00% | 0.00% | 145M | ||
| 1st Jan change | Capi. | |
|---|---|---|
| -5.26% | 145M | |
| +25.58% | 661B | |
| +26.74% | 566B | |
| -6.60% | 352B | |
| +19.68% | 332B | |
| +3.56% | 283B | |
| +13.43% | 231B | |
| +4.71% | 200B | |
| -9.53% | 195B | |
| -5.25% | 145B |
I-MAB 
